Yonhap Infomax NewsRakuten Medical is advancing its light-based Alluminox cancer therapy, aiming to minimize side effects and improve patient quality of life, with plans for global expansion and entry into the South Korean market through partnerships with Lotte Biologics and local ventures.
#YonhapInfomax
#RakutenMedical #Alluminox #CancerTherapy #LotteBiologics #Photoimmunotherapy
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=84992
#YonhapInfomax
#RakutenMedical #Alluminox #CancerTherapy #LotteBiologics #Photoimmunotherapy
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=84992
Rakuten Medical CEO – 'Maintaining Quality of Life for Cancer Patients with Light-Based Therapy… Eyes on Korean Market'
Rakuten Medical is advancing its light-based Alluminox cancer therapy, aiming to minimize side effects and improve patient quality of life, with plans for global expansion and entry into the South Korean market through partnerships with Lotte Biologics and local ventures.